Markets

NextEra, Danaher, Rhythm Pharmaceuticals and more

    0
    Share on Facebook Share on Twitter


    Wind turbines at the San Gorgonio Pass wind farm, owned by NextEra Energy Inc., in Whitewater, California, on Wednesday, Feb. 17, 2021.

    Bing Guan | Bloomberg | Getty Images

    Check out the companies making headlines after hours.

    NextEra Energy — Shares fell 3% in extended trading after the company announced its intent to sell $2 billion in equity units. Each equity unit will be issued in the amount of $50 and will consist of a contract to purchase NextEra Energy common stock in the future, as well as a 5% undivided beneficial ownership interest in a NextEra Energy Capital Holdings debenture due Sept. 1, 2027, issued in the principal amount of $1,000.

    Danaher — The medical company saw shares rise 4% after announcing plans to spin off its environmental and applied solutions business to create an independent, publicly traded company. It also raised its third-quarter revenue guidance, according to FactSet.

    Rhythm Pharmaceuticals — Shares of Rhythm Pharmaceuticals fell about 11% after the company announced a $100 million stock offering.

    Arconic Corp — The manufacturing company’s shares slid about 8% after Arconic provided a lower-than-previously-expected revenue forecast for the full year, citing the impact of operational issues and the combination of demand declines and higher unhedged energy costs in Europe.



    Originally Published Here -Source link

    0 0 votes
    Article Rating

    The Fed is going to pivot in 3 stages, author Nomi Prins says

    Previous article

    FX Weekly: U.S. Inflation Report Sparks Big Moves

    Next article

    You may also like

    More in Markets

    Subscribe
    Notify of
    guest
    0 Comments
    Inline Feedbacks
    View all comments